Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Idioma
Intervalo de año de publicación
2.
Anesteziol Reanimatol ; (5): 98-102, 1997.
Artículo en Ruso | MEDLINE | ID: mdl-9432904

RESUMEN

Analgesia with nonsteroid antiinflammatory drugs (NSAID) becomes a pressing problem today. One such drug is ketorolak tromethamine (KT), characterized by expressed analgesic activity comparable with that of opioid analgesics morphine or promedol. Our purpose was to assess KT efficacy in analgesia performed by different methods, including analgesia controlled by the patient (ACP) after surgery. In medium severe and strong pain KT was used in group I (n = 60) "as needed" in a dose of 30 mg up to 3-4 times a day, in group 2 (n = 12) by the ACP method, in group 3 (n = 16) KT was incessantly infused in a daily dose of up to 120 mg, and in group 4 (n = 11) KT was injected 3-4 times a day in a dose of 30 mg in combination with morphine ACP. The results indicate a high efficacy of KT: 83% after a single injection. Combined use of KT and promedol decreased the dose by 40-50%. Side effects were observed in 15% of patients: most often it was a sense of fever and sweating (in 4% of patients), nausea and vomiting (in 2%), insomnia (in 2%). ACP and planned injections in a daily dose of 90-120 mg is the optimal method of analgesia in patients after extensive surgical interventions.


Asunto(s)
Analgésicos no Narcóticos/administración & dosificación , Dolor Postoperatorio/tratamiento farmacológico , Tolmetina/análogos & derivados , Trometamina/análogos & derivados , Adolescente , Adulto , Anciano , Analgesia Controlada por el Paciente , Analgésicos no Narcóticos/efectos adversos , Analgésicos Opioides/administración & dosificación , Quimioterapia Combinada , Estudios de Evaluación como Asunto , Femenino , Humanos , Inyecciones Intramusculares , Inyecciones Subcutáneas , Ketorolaco Trometamina , Masculino , Persona de Mediana Edad , Morfina/administración & dosificación , Dolor/tratamiento farmacológico , Periodo Posoperatorio , Promedol/administración & dosificación , Tolmetina/administración & dosificación , Tolmetina/efectos adversos , Trometamina/administración & dosificación , Trometamina/efectos adversos
5.
Anesteziol Reanimatol ; (5): 22-4, 1991.
Artículo en Ruso | MEDLINE | ID: mdl-1767948

RESUMEN

Basic changes in receptor-controlled platelet calcium metabolism that occur in the early postoperative period under the effect of aggregation-inducing hormones--platelet activation factor (PAF), adenosine phosphate (ADP) and vasopressin--are reviewed. Patients after lung surgery and patients with ischemic heart disease after aortocoronary bypass surgery have been examined. Patients operated on for malignant lung tumours developed increased postoperative sensitivity to ADP, while in patients after aortocoronary bypass surgery the early postoperative period was characterized by decreased sensitivity to PAF and vasopressin.


Asunto(s)
Plaquetas/metabolismo , Calcio/sangre , Enfermedad Coronaria/cirugía , Neoplasias Pulmonares/cirugía , Adenosina Difosfato/fisiología , Adulto , Anciano , Enfermedad Coronaria/sangre , Humanos , Neoplasias Pulmonares/sangre , Persona de Mediana Edad , Factor de Activación Plaquetaria/fisiología , Periodo Posoperatorio , Vasopresinas/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA